biote Corp.
Company Information
Industry Medicinal Chemicals & Botanical Products
SIC Code 2833
Entity Type operating
SEC Category Emerging growth company
Business Address 1875 W. WALNUT HILL LN #100, IRVING, TX, 75038
Mailing Address 1875 W. WALNUT HILL LN #100, IRVING, TX, 75038
Phone 972-486-9346
Fiscal Year End 1231
EIN 851791125
Financial Overview
FY2024
$3.32M
Net Income
-$29.40M
Stockholders' Equity
$0.13
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | January 26, 2026 | View on SEC |
| 10-Q Quarterly financial report | November 7, 2025 | View on SEC |
| 8-K Current report of material events | November 5, 2025 | View on SEC |
| 10-Q Quarterly financial report | August 8, 2025 | View on SEC |
| 8-K Current report of material events | August 6, 2025 | View on SEC |
| SCHEDULE 13D Beneficial ownership report (>5%) | June 12, 2025 | View on SEC |
| 4 Insider stock transaction report | June 11, 2025 | View on SEC |
| 8-K Current report of material events | June 9, 2025 | View on SEC |
| 8-K Current report of material events | June 5, 2025 | View on SEC |
| 4 Insider stock transaction report | May 15, 2025 | View on SEC |
Material Events
8-K Legal Issue January 26, 2026
High Impact
- Biote's subsidiary, Asteria Health, initiated a voluntary recall of specific hormone pellets due to potential metal particles.
- The company anticipates a one-time charge of $1.3 million in the fourth quarter of 2025 and another $1.0 million projected for 2026 for recall-related expenses.
Related Companies
Companies in the same industry (SIC: 2833)
Charlie's Holdings, Inc.
CHUC Medicinal Chemicals & Botanical Products
Canopy Growth Corp
CGC Medicinal Chemicals & Botanical Products
Bon Natural Life Ltd
BON Medicinal Chemicals & Botanical Products
Medikra Inc.
MDKR Medicinal Chemicals & Botanical Products
AKANDA CORP.
AKAN Medicinal Chemicals & Botanical Products
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.